Disc Medicine, Inc.
74.51USD
-0.5200 (-0.69%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on IRON.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | -65 | -70 | -67 | -68 | -61 | -40 | -35 | -33 |
| Net Income | -60 | -64 | -61 | -62 | -55 | -34 | -29 | -27 |
| EPS (Diluted) | -$1.54 | -$1.65 | -$1.62 | -$1.77 | -$1.58 | -$1.02 | -$0.98 | -$0.89 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)